Search research articles
Contact Us
Filters
Showing results (41-50 of 78) with videos related to
Page
of 8
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
September 25, 2025
Bone marrow scintigraphy as a prognostic marker of overall survival in mCRPC patients treated with Radium-223 dichloride
Qaid Ahmed Shagera, Olivier Gheysens, Emilie Jonard, et al.
European Urology Oncology
|
October 10, 2025
Efficacy of [<sup>177</sup>Lu]Lu-PSMA-617 in Patients with Metastatic Clear-cell Renal Cell Carcinoma: The Multicentre, Single-arm, Phase 2 RENALUT Trial
Emmanuel Seront, Mehdi Bsilat, Karolien Goffin, et al.
Frontiers in Oncology
|
April 4, 2019
Phase 1 Study Evaluating the Association of the Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib and Cetuximab in Recurrent/Metastatic p16-Negative Squamous Cell Carcinoma of the Head and Neck
Emmanuel Seront, Sandra Schmitz, Matthias Papier, et al.
Targeted Oncology
|
February 6, 2020
c-MET as a Potential Resistance Mechanism to Everolimus in Breast Cancer: From a Case Report to Patient Cohort Analysis
Valentin Van den Bossche, Gaspard Jadot, Guillaume Grisay, et al.
BMC Pulmonary Medicine
|
September 13, 2024
Clinical and radiological pattern of olaparib-induced interstitial lung disease
Alexandre Brudon, Dorine Fournier, Frédéric Selle, et al.
Orphanet Journal of Rare Diseases
|
October 31, 2018
Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II study
Jennifer Hammer, Emmanuel Seront, Steven Duez, et al.
BJU International
|
January 19, 2016
Phase II study of dual phosphoinositol-3-kinase (PI3K) and mammalian target of rapamycin (mTOR) inhibitor BEZ235 in patients with locally advanced or metastatic transitional cell carcinoma
Emmanuel Seront, Sylvie Rottey, Bertrand Filleul, et al.
Clinical and Translational Radiation Oncology
|
March 31, 2025
Stereotactic body radiotherapy for lung oligometastatic prostate cancer: An international retrospective multicenter study
Maximilien Rogé, Patrick Bowden, Paul Conway, et al.
Frontiers in Oncology
|
October 29, 2025
A case report of malignant hypertension and multiorgan dysfunction during immunotherapy for gallbladder cancer
Caroline Anthon, Hugo Pierret, Frederic Houssiau, et al.
Nature Cardiovascular Research
|
August 28, 2024
A case report of sirolimus use in early fetal management of lymphatic malformation
Emmanuel Seront, Jean Marc Biard, An Van Damme, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 78) with videos related to
Sort By:
Page
of 8
European Journal of Nuclear Medicine and Molecular Imaging
|
September 25, 2025
Bone marrow scintigraphy as a prognostic marker of overall survival in mCRPC patients treated with Radium-223 dichloride
Qaid Ahmed Shagera, Olivier Gheysens, Emilie Jonard, et al.
European Urology Oncology
|
October 10, 2025
Efficacy of [<sup>177</sup>Lu]Lu-PSMA-617 in Patients with Metastatic Clear-cell Renal Cell Carcinoma: The Multicentre, Single-arm, Phase 2 RENALUT Trial
Emmanuel Seront, Mehdi Bsilat, Karolien Goffin, et al.
Frontiers in Oncology
|
April 4, 2019
Phase 1 Study Evaluating the Association of the Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib and Cetuximab in Recurrent/Metastatic p16-Negative Squamous Cell Carcinoma of the Head and Neck
Emmanuel Seront, Sandra Schmitz, Matthias Papier, et al.
Targeted Oncology
|
February 6, 2020
c-MET as a Potential Resistance Mechanism to Everolimus in Breast Cancer: From a Case Report to Patient Cohort Analysis
Valentin Van den Bossche, Gaspard Jadot, Guillaume Grisay, et al.
BMC Pulmonary Medicine
|
September 13, 2024
Clinical and radiological pattern of olaparib-induced interstitial lung disease
Alexandre Brudon, Dorine Fournier, Frédéric Selle, et al.
Orphanet Journal of Rare Diseases
|
October 31, 2018
Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II study
Jennifer Hammer, Emmanuel Seront, Steven Duez, et al.
BJU International
|
January 19, 2016
Phase II study of dual phosphoinositol-3-kinase (PI3K) and mammalian target of rapamycin (mTOR) inhibitor BEZ235 in patients with locally advanced or metastatic transitional cell carcinoma
Emmanuel Seront, Sylvie Rottey, Bertrand Filleul, et al.
Clinical and Translational Radiation Oncology
|
March 31, 2025
Stereotactic body radiotherapy for lung oligometastatic prostate cancer: An international retrospective multicenter study
Maximilien Rogé, Patrick Bowden, Paul Conway, et al.
Frontiers in Oncology
|
October 29, 2025
A case report of malignant hypertension and multiorgan dysfunction during immunotherapy for gallbladder cancer
Caroline Anthon, Hugo Pierret, Frederic Houssiau, et al.
Nature Cardiovascular Research
|
August 28, 2024
A case report of sirolimus use in early fetal management of lymphatic malformation
Emmanuel Seront, Jean Marc Biard, An Van Damme, et al.
Page
of 8